Immune-Mediated Viral Control With Budigalimab ± Trosunilimab: First Results of Phase II Global RCT
CROI 2026 Feb 22-25 Denver
Beatriz Mothe, Ana Gabriela Pires Dos Santos, Jay Lalezari, Ricardo Diaz, Linos Vandekerckhove, Preethi Krishnan, Andrew Topp, Axel Baumgarten, Tien-Yi Lee, Heide Betman, Manal Abunimeh, Jean-Pierre Routy, Jonathan Z. Li, Steven Deeks
